Literature DB >> 24053223

Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study.

L-M Sun1, C-L Lin, C-J Chung, J-A Liang, F-C Sung, C-H Kao.   

Abstract

BACKGROUND AND
PURPOSE: Studies have suggested that multiple sclerosis (MS) might be linked to an overall reduced cancer rate, but a positive relationship is also found for several types of cancer. This study determines whether MS is associated with cancer risk in Taiwan.
METHODS: Data from the National Health Insurance System of Taiwan were used to assess this issue. The MS cohort included 1292 patients, and each patient was randomly frequency-matched with four participants without MS, based on their age, sex and index year (control cohort). Cox proportional hazards regression analysis was conducted to estimate the influence of MS on cancer risk.
RESULTS: A significantly higher risk of developing overall cancer was found amongst the MS cohort compared with the control cohort [adjusted hazard ratio (HR) 1.85, 95% confidence interval (CI) 1.26-2.74], as well as breast cancer (adjusted HR 2.23, 95% CI 1.11-4.46).
CONCLUSIONS: The nationwide population-based cohort study revealed that Taiwanese patients with MS have a higher risk of developing overall cancer types and breast cancer in particular.
© 2013 The Author(s) European Journal of Neurology © 2013 EFNS.

Entities:  

Keywords:  breast cancer; cancer; cohort study; multiple sclerosis

Mesh:

Year:  2013        PMID: 24053223     DOI: 10.1111/ene.12267

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  16 in total

1.  Annotation of functional variation within non-MHC MS susceptibility loci through bioinformatics analysis.

Authors:  F B S Briggs; L J Leung; L F Barcellos
Journal:  Genes Immun       Date:  2014-07-17       Impact factor: 2.676

2.  Occurrence of malignant diseases in patients with multiple sclerosis: population-based MS Registry data.

Authors:  Gorica Maric; Tatjana Pekmezovic; Sarlota Mesaros; Olivera Tamas; Nikola Veselinovic; Maja Budimkic Stefanovic; Aleksa Jovanovic; Jelena Drulovic
Journal:  Neurol Sci       Date:  2022-08-30       Impact factor: 3.830

3.  SNHG1 Long Noncoding RNA is Potentially Up-Regulated in Colorectal Adenocarcinoma.

Authors:  Niloofar Avazpour; Mohamadreza Hajjari; Seyed Reza Kazemi Nezhad; Maryam Tahmasebi Birgani
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01

Review 4.  A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Gary Cutter; Stephen Reingold; Per Soelberg Sorensen
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 5.  A systematic review of the incidence and prevalence of cancer in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sorensen; Stephen C Reingold; Gary Cutter
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 6.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

7.  Infective Endocarditis and Cancer Risk: A Population-Based Cohort Study.

Authors:  Li-Min Sun; Jung-Nan Wu; Cheng-Li Lin; Jen-Der Day; Ji-An Liang; Li-Ren Liou; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

8.  Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran.

Authors:  Masoud Etemadifar; Hamidreza Jahanbani-Ardakani; Sara Ghaffari; Maboobeh Fereidan-Esfahani; Hossein Changaei; Nazila Aghadoost; Ameneh Jahanbani Ardakani; Negin Moradkhani
Journal:  Caspian J Intern Med       Date:  2017

9.  Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.

Authors:  Mohammadhossein Hajiebrahimi; Scott Montgomery; Sarah Burkill; Shahram Bahmanyar
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

10.  Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis.

Authors:  Charles Dolladille; Basile Chrétien; Laure Peyro-Saint-Paul; Joachim Alexandre; Olivier Dejardin; Sophie Fedrizzi; Gilles Defer
Journal:  Neurotherapeutics       Date:  2021-07-06       Impact factor: 6.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.